Figure 2. Prostate-Specific Antigen (PSA) Screening, Prostate Biopsy, and Prostate Cancer Incidence Rates by Racial and Ethnic Group.

Long-term nonscreening rates represent the proportion of patients without a PSA screening test in the prior 3 years. All rates were pooled across 128 Veterans Health Administration facilities. “Other” included Asian and Hispanic men. Vertical dashed line represents the year of US Preventive Services Task Force screening guideline publication in 2012.